These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 1683123)

  • 21. Altered splenic T cell function of BALB/cByJ mice infected with mouse hepatitis virus or Sendai virus.
    Smith AL; Bottomly K; Winograd DF
    J Immunol; 1987 May; 138(10):3426-30. PubMed ID: 2437194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
    Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
    Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential activation of Th2 cells in chronic graft-versus-host reaction.
    De Wit D; Van Mechelen M; Zanin C; Doutrelepont JM; Velu T; Gérard C; Abramowicz D; Scheerlinck JP; De Baetselier P; Urbain J
    J Immunol; 1993 Jan; 150(2):361-6. PubMed ID: 8419469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graft-vs-host reactions (GVHR) across minor murine histocompatibility barriers. II. Development of natural suppressor cell activity.
    Maier T; Holda JH; Claman HN
    J Immunol; 1985 Sep; 135(3):1644-51. PubMed ID: 3160774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alloreactive lymphocytes from T cell receptor (beta-chain) transgenic mice do not mediate a graft-versus-host reaction.
    Rimm IJ; Ghayur T; Gasser DL; Rosenkrantz K; Burakoff SJ; Seidman JG; Ferrara JL
    J Immunol; 1991 Feb; 146(4):1130-3. PubMed ID: 1825104
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy.
    Johnson BD; Becker EE; LaBelle JL; Truitt RL
    J Immunol; 1999 Dec; 163(12):6479-87. PubMed ID: 10586039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of lymphokine mRNA and protein synthesis in vivo in a murine graft-vs-host reaction.
    Kelso A; Troutt AB
    Transplant Proc; 1993 Feb; 25(1 Pt 1):122-4. PubMed ID: 8438247
    [No Abstract]   [Full Text] [Related]  

  • 28. Lymphokine activity production in graft-versus-host reactions across minor histocompatibility antigen barriers.
    Hirokawa M; Takatsu H; Ohshima A; Chubachi A; Kudo K; Niitsu H; Takahashi T; Yoshida K; Miura AB
    Clin Exp Immunol; 1989 Sep; 77(3):434-9. PubMed ID: 2530013
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TH1 and TH2 dependent cytokines in experimental autoimmunity and immune reactions induced by chemicals.
    Dubey C; Bellon B; Druet P
    Eur Cytokine Netw; 1991; 2(3):147-52. PubMed ID: 1832570
    [No Abstract]   [Full Text] [Related]  

  • 30. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
    Moser M; Sharrow SO; Shearer GM
    J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recovery of T cell populations after acute graft-vs-host reaction.
    Hakim FT; Payne S; Shearer GM
    J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of macrophages in the pathogenesis of experimental tick-borne encephalitis in mice.
    Khozinsky VV; Semenov BF; Gresíková M; Chunikhin SP; Sekeyová M; Kozuch O
    Acta Virol; 1985 May; 29(3):194-202. PubMed ID: 2864820
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes of natural killer cell activity in different mouse lines by acute and asymptomatic flavivirus infections.
    Vargin VV; Semenov BF
    Acta Virol; 1986 Jul; 30(4):303-8. PubMed ID: 2876611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the thymus in control of autoreactivity or allotolerance in syngeneic and allogeneic bone marrow chimeras treated with bacterial adjuvants.
    Taniguchi K; Gondo H; Nomoto K
    J Immunol; 1984 Oct; 133(4):1735-9. PubMed ID: 6088626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic versus syngeneic killer splenocytes as effector cells for the induction of graft-versus-tumor effect.
    Morecki S; Yacovlev E; Gelfand Y; Vilensky A; Slavin S
    Biol Blood Marrow Transplant; 2004 Jan; 10(1):40-8. PubMed ID: 14752778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unconventional NK1.1(-) intermediate TCR cells as major T lymphocytes expanding in chronic graft-versus-host disease.
    Miyakawa R; Miyaji C; Watanabe H; Yokoyama H; Tsukada C; Asakura H; Abo T
    Eur J Immunol; 2002 Sep; 32(9):2521-31. PubMed ID: 12207336
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intermediate TCR cells with self-reactive clones are effector cells which induce syngeneic graft-versus-host disease in mice.
    Osman Y; Watanabe T; Kawachi Y; Sato K; Ohtsuka K; Watanabe H; Hashimoto S; Moriyama Y; Shibata A; Abo T
    Cell Immunol; 1995 Dec; 166(2):172-86. PubMed ID: 7497519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
    Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
    J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
    Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
    Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.